AMEX:SENS   Senseonics Holdings, Inc.
SENS: Many in private have asked me what I thought of GME and if from my ideas something highly explosive like GME could be born in a short time, my answer was the following ... OCGN and SENS .....

Sens why? So FDA approval of their 180-day monitor is forthcoming. It was delayed due to Covid, not a trial failure (the system is already used outside the US)
Their new partner, Ascencia, seems more suitable than their previous partner Roche & George Soros is more attached to this pennystock.

With a 5 mm cut they bring the sensor into the arm. First of all this is very good so you can't really see the sensor from the outside what all other sensor manufacturers have like DEXCOM. the only thing you have on your arm is a device that detects your sugar level signal. You can take it off and put it back on. The sensor will vibrate when you are too high or low. You just have to replace it every 180 days (another 10 days).

Let's get to the core ... DEXCOM's first competitors ($ 400 per share is worth) you know who it is? Yes it is SENS .... So from 2.98 $ I'm there ... over 5.5$ all as GME is relly possibily

I hope my idea can make you understand that behind the results, there are researches ... Happy Trading everyone

www.paypal.me/mauretto432

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.